Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation—Is It Feasible to Develop Evidence-Based Guidelines?

Clozapine is the only antipsychotic that is effective in treatment-resistant schizophrenia. However, in certain clinical situations, such as the emergence of serious adverse effects, it is necessary to discontinue clozapine. Stopping clozapine treatment poses a particular challenge due to the risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackman, Graham, Oloyede, Ebenezer, Horowitz, Mark, Harland, Robert, Taylor, David, MacCabe, James, McGuire, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781383/
https://www.ncbi.nlm.nih.gov/pubmed/34651184
http://dx.doi.org/10.1093/schbul/sbab103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781383/
https://www.ncbi.nlm.nih.gov/pubmed/34651184
http://dx.doi.org/10.1093/schbul/sbab103

Ejemplares similares